SPONSOR
Shenyang Sunshine Pharmaceutical Co., LTD.
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 2
Shenyang Sunshine Pharmaceutical Co., LTD. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Malignant Tumors, First-line Advanced NSCLC Patients, Gout, Hyperuricemia.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shenyang Sunshine Pharmaceutical Co., LTD.
How many clinical trials has Shenyang Sunshine Pharmaceutical Co., LTD. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Shenyang Sunshine Pharmaceutical Co., LTD., of which 3 are actively recruiting participants. These trials cover conditions including Malignant Tumors, First-line Advanced NSCLC Patients, Gout. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shenyang Sunshine Pharmaceutical Co., LTD. research focus on?
Shenyang Sunshine Pharmaceutical Co., LTD. clinical trials span Malignant Tumors, First-line Advanced NSCLC Patients, Gout, Hyperuricemia. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shenyang Sunshine Pharmaceutical Co., LTD. clinical trial?
To participate in a Shenyang Sunshine Pharmaceutical Co., LTD. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shenyang Sunshine Pharmaceutical Co., LTD. trials with current recruitment status updated daily.
Clinical Trials by Shenyang Sunshine Pharmaceutical Co., LTD.
NCT06944444 Phase 1
Recruiting
A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors
Malignant Tumors
NCT07171606 Phase 2
Recruiting
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
First-line Advanced NSCLC Patients
NCT06629376 Phase 1
Recruiting
Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia
Gout
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology